Michael Wijaranakula

Michael Wijaranakula's work experience includes holding the position of Director, Business Development and Corporate Strategy at Solid Biosciences since January 2023. Prior to that, they worked as the Director, Office of the CSO at Solid Biosciences from October 2021 to January 2023. Before joining Solid Biosciences, Michael worked as a Senior Associate at Kendall Advisory from June 2020 to October 2021. Michael also worked as an MBA (Summer) Associate at Locust Walk from June 2019 to May 2020 and as a Market Analyst Intern - Technology Development Fund at Boston Children's Hospital from January 2019 to May 2019. Their earlier experience includes working as a Senior Research Associate and Research Associate at Novo Nordisk from November 2016 to July 2018 and August 2013 to November 2016, respectively.

Michael Wijaranakula obtained a Master of Business Administration (MBA) degree from the Questrom School of Business at Boston University between 2018 and 2020. Prior to that, they pursued a degree in Cellular Molecular and Developmental Biology with a focus on Biological and Biomedical Sciences at the University of Washington from 2007 to 2010.